Education
About Us
Working with TipRanks
Follow Us
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
MDNAF Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDNAF Stock 12 Month Forecast
There Are No Analyst Ratings for MDNAF In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
MDNAF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bloom Burton
$2.92
Buy
371.51%
Upside
Reiterated
12/11/25
We have also adjusted our assumption for a $50M near term equity issuance at $2.00 to $1.10. The mixed data at ESMO-IO and resulting adjustments to our model have reduced our target price to C$4.00* (previously US$6.00). Nevertheless, MDNA stock remains a BUY (Speculative) as we continue to believe that MDNA11 is active. The company held $15.7M at September 30, burning approximately $5M/quarter.
Lucid Capital
$2.92
Buy
371.51%
Upside
Initiated
10/14/25
H.C. Wainwright
$2.5
Buy
303.23%
Upside
Reiterated
08/04/25
Research Capital
$2.74
Buy
342.04%
Upside
Reiterated
04/28/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bloom Burton
$2.92
Buy
371.51%
Upside
Reiterated
12/11/25
We have also adjusted our assumption for a $50M near term equity issuance at $2.00 to $1.10. The mixed data at ESMO-IO and resulting adjustments to our model have reduced our target price to C$4.00* (previously US$6.00). Nevertheless, MDNA stock remains a BUY (Speculative) as we continue to believe that MDNA11 is active. The company held $15.7M at September 30, burning approximately $5M/quarter.
Lucid Capital
$2.92
Buy
371.51%
Upside
Initiated
10/14/25
H.C. Wainwright
$2.5
Buy
303.23%
Upside
Reiterated
08/04/25
Research Capital
$2.74
Buy
342.04%
Upside
Reiterated
04/28/25
Best Analysts Covering Medicenna Therapeutics Corp
3 Months
xxx
Success Rate
5/8 ratings generated profit
Average Return
+57.39%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +57.39% per trade.
1 Year
Success Rate
6/8 ratings generated profit
Average Return
+203.44%
Copying Andre Uddin's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +203.44% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
Average Return
+94.29%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +94.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDNAF Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
3
3
1
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
1
1
0
Each month's total comprises the sum of three months' worth of ratings.
MDNAF Stock Forecast FAQ
What is MDNAF’s average 12-month price target, according to analysts?
Currently, no data Available
What is MDNAF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MDNAF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDNAF a Buy, Sell or Hold?
Currently, no data Available
What is Medicenna Therapeutics Corp’s price target?
Currently, no data Available
What do analysts say about Medicenna Therapeutics Corp?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of MDNAF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.